13D Filing: Longitude Capital Partners, Llc and Corcept Therapeutics Inc (NASDAQ:CORT)

Page 10 of 10

Page 10 of 10 – SEC Filing

CUSIP No. 218352102 13D Page 10 of 10 Pages

SCHEDULE A

Name of Reporting Person

Date of
Transaction
No. of Shares Sale Price Per
Share of
Common Stock
(1)
LVP 03/08/2017 735,263 $ 9.75
LCA 03/08/2017 14,737 $ 9.75
LVP 03/13/2017 20,568 $ 11.1292 (2) 
LCA 03/13/2017 412 $ 11.1291 (2) 
LVP 03/14/2017 294,105 $ 10.0089 (3) 
LCA 03/14/2017 5,895 $ 10.0089 (3)
LVP 03/15/2017 273,573 $ 10.2386 (4)
LCA 03/15/2017 5,483 $ 10.2372 (4)
LVP 03/16/2017 264,650 $ 9.9396 (5)
LCA 03/16/2017 5,305 $ 9.9381 (5)
Ms. Bakker 03/17/2017 30,000 $ 9.8227

_____________

(1) The Reporting Persons hereby undertake to provide upon request to the Commission staff, the Issuer or a security holder of
the Issuer full information regarding the number of shares and prices at which the sales were effected.
(2) Reflects the weighted average sale price, for multiple transactions executed at prices ranging from $11.10 to $11.305 per share.
(3) Reflects the weighted average sale price, for multiple transactions executed at prices ranging from $9.90 to $10.37 per share.
(4) Reflects the weighted average sale price, for multiple transactions executed at prices ranging from $10.14 to $10.36 per share.
(5) Reflects the weighted average sale price, for multiple transactions executed at prices ranging from $9.855 to $10.255 per share.

Follow Corcept Therapeutics Inc (NASDAQ:CORT)

Page 10 of 10